ANG Lifesciences India Limited
Latest filings
- RTA compliance certificate filed under SEBI Reg 74(5) for Sep 2026 quarter · Compliance
- 20th AGM voting results: all 5 resolutions passed · Compliance
- Mrs. Chetna re-appointed as Independent Director for 5-year term · Management Changes
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹93 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from ANG Lifesciences India Limited's filed financials and exchange disclosures
What does ANG Lifesciences India Limited do?
ANG Lifesciences India Limited is a Pharmaceuticals & Biotechnology company listed on BSE.
Is ANG Lifesciences India Limited profitable?
No. Over the trailing twelve months ANG Lifesciences India Limited reported a net loss of ₹11 Cr on revenue of ₹93 Cr.
Does ANG Lifesciences India Limited pay a dividend?
Not in the latest reported year — ANG Lifesciences India Limited's dividend payout for FY26 was nil.
Is ANG Lifesciences India Limited debt-free?
No. It reported borrowings of ₹78 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹77 Cr after cash. Debt stands at 1.47× equity. That is higher than 96% of its 166 Pharmaceuticals peers.
Is ANG Lifesciences India Limited expensive compared with its peers?
On trailing P/E, ANG Lifesciences India Limited ranks 5 of 158 in Pharmaceuticals — cheaper than 98% of them, against an industry median of 29.7×. This is a position, not a valuation judgement.
How much does the ANG Lifesciences India Limited share price move in a day?
On a typical session ANG Lifesciences India Limited moves 2.21% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track ANG Lifesciences India Limited's announcements?
Every NSE and BSE filing by ANG Lifesciences India Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.